AlphaYouIC
Schedule 13G filing
Ikarian Capital, LLC cut its Quoin Pharmaceuticals Ltd. (QNRX) stake below 5%
Ikarian Capital, LLC reported owning 4.4% of Quoin Pharmaceuticals Ltd. (QNRX) (211,538 shares) in a Schedule 13G filed Oct 7, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Oct 7, 2026
- Source
- Schedule 13G
More QNRX insider and Congress trades
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.